LADENBURG THALMANN FINANCIAL SERVICES INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2019$66,000
-2.9%
826
-10.9%
0.00%
Q3 2019$68,000
-34.6%
927
-15.5%
0.00%
-100.0%
Q2 2019$104,000
+92.6%
1,097
+62.8%
0.00%
Q1 2019$54,000
+800.0%
674
+518.3%
0.00%
Q4 2018$6,000
+20.0%
109
+62.7%
0.00%
Q3 2018$5,0000.0%67
+34.0%
0.00%
Q2 2018$5,0000.0%500.0%0.00%
Q1 2018$5,000
-66.7%
50
-74.4%
0.00%
Q4 2017$15,000
+50.0%
195
+34.5%
0.00%
Q3 2017$10,0001450.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders